Treatment of poor-risk neuroblastoma patients with high-dose chemotherapy and autologous peripheral stem cell rescue.
about
High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastomaHigh-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastomaHigh-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastomaEfficacy of tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma: the Korean Society of Pediatric Hematology-Oncology experience over 6 years (2000-2005).Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma.A Novel Mechanism of Spine Damages in Stroke via DAPK1 and Tau.High-dose chemotherapy and autologous stem cell rescue in patients with high-risk stage 3 neuroblastoma: 10-year experience at a single center.Long-term results of high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma patients: a report of the Spanish working party for BMT in children (Getmon).Synergism of buthionine sulfoximine and melphalan against neuroblastoma cell lines derived after disease progression.Tau proteins in the temporal and frontal cortices in patients with vascular dementia.Functional characterization of FTDP-17 tau gene mutations through their effects on Xenopus oocyte maturation.
P2860
Q24186636-0CA69DC2-6892-42C5-8B43-80D38CBA42B9Q24200296-E7874EF4-E0BB-402B-8A6A-7151E8C138F1Q24235309-9D61A07E-8528-4E97-ACC6-B3A26CD6EC39Q33807214-9881E459-E74D-45A2-A226-3BDE37774C2AQ34660375-3057F362-41CA-44D6-ADB0-42E0C7D45176Q36754052-06AAA2D1-2333-4E50-8111-9B63F1A32E48Q37284671-23CE771D-195D-4785-BED3-C24E5286B822Q43680012-6E89BE9E-77B1-427B-B930-A6E376B4EBC6Q46419102-824E66C0-140F-4CF5-9E66-16B8920CB8F0Q46788633-1476518E-82BF-4743-9120-00D5362A7B28Q48872444-804B0356-1C80-4681-9602-743F1A162714
P2860
Treatment of poor-risk neuroblastoma patients with high-dose chemotherapy and autologous peripheral stem cell rescue.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Treatment of poor-risk neurobl ...... s peripheral stem cell rescue.
@en
Treatment of poor-risk neurobl ...... s peripheral stem cell rescue.
@nl
type
label
Treatment of poor-risk neurobl ...... s peripheral stem cell rescue.
@en
Treatment of poor-risk neurobl ...... s peripheral stem cell rescue.
@nl
prefLabel
Treatment of poor-risk neurobl ...... s peripheral stem cell rescue.
@en
Treatment of poor-risk neurobl ...... s peripheral stem cell rescue.
@nl
P2093
P356
P1476
Treatment of poor-risk neurobl ...... s peripheral stem cell rescue.
@en
P2093
Katzenstein HM
P2888
P304
P356
10.1038/SJ.BMT.1700932
P407
P577
1997-10-01T00:00:00Z